{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"126-646-055-050-77X","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"126-646-055-050-77X","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11836,"type":"PATENT","title":"University of Cape Town Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":831,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8448,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately: univ* AND Cape AND Town. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 754
Search Applicants and Owners separately: univ* AND Cape AND Town. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 754
administering to a subject in need of treatment for atherosclerosis a therapeutically effective amount of a complement inhibitor, wherein the complement inhibitor is a vaccinia virus complement control protein (VCP) or fragment thereof."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the subject is a mammal."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 2, wherein the subject is a human."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein administering to the subject the complement inhibitor comprises intravenously injecting into the subject the complement inhibitor."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the therapeutically effective amount of the complement inhibitor ranges from about 0.01 g/kg to about 0.1 g/kg per dose."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["A method of inhibiting the production or progression of one or more atherosclerotic lesions within the vasculature of a subject, comprising:\n
administering to a subject having one or more atherosclerotic lesions a therapeutically effective amount of a complement inhibitor, wherein the complement inhibitor is a vaccinia virus complement control protein (VCP) or fragment thereof."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein the subject is a mammal."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 7, wherein the subject is a human."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein administering to the subject the complement inhibitor comprises intravenously injecting into the subject the complement inhibitor."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein the therapeutically effective amount of the complement inhibitor ranges from about 0.01 g/kg to about 0.1 g/kg per dose."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 6, wherein the vasculature comprises a cardiac artery."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 11, wherein the vasculature comprises an aorta."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["A method for treating a reperfusion injury, comprising:\n
administering to a subject in need of treatment for a reperfusion injury a therapeutically effective amount of a vaccinia complement control protein (VCP) or fragment thereof."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 13, wherein the subject is a mammal."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 14, wherein the subject is a human."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 14, wherein the VCP or fragment thereof is administered prior to or during reperfusion of a coronary artery."],"number":16,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 13, wherein the VCP or fragment thereof is administered as a single bolus treatment."],"number":17,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}